Evgenia Dobrinskikh
Concepts (381)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucin-5B | 10 | 2024 | 224 | 2.550 |
Why?
| | Idiopathic Pulmonary Fibrosis | 13 | 2025 | 653 | 2.060 |
Why?
| | Lung | 12 | 2025 | 4066 | 1.570 |
Why?
| | Acetaminophen | 4 | 2025 | 269 | 1.520 |
Why?
| | Hernias, Diaphragmatic, Congenital | 3 | 2020 | 201 | 1.520 |
Why?
| | Lung Injury | 3 | 2021 | 218 | 1.320 |
Why?
| | Fetus | 5 | 2025 | 807 | 1.160 |
Why?
| | Bleomycin | 5 | 2023 | 247 | 0.940 |
Why?
| | Liver | 8 | 2025 | 1940 | 0.910 |
Why?
| | Endocytosis | 4 | 2014 | 168 | 0.840 |
Why?
| | Respiratory Mucosa | 3 | 2025 | 324 | 0.760 |
Why?
| | Podocytes | 6 | 2019 | 63 | 0.760 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 2 | 2013 | 9 | 0.750 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2021 | 285 | 0.750 |
Why?
| | Kidney Tubules, Proximal | 2 | 2013 | 128 | 0.700 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2020 | 49 | 0.670 |
Why?
| | Therapeutic Occlusion | 1 | 2020 | 3 | 0.670 |
Why?
| | Animals | 46 | 2025 | 37011 | 0.650 |
Why?
| | Fetal Therapies | 1 | 2020 | 40 | 0.640 |
Why?
| | Organogenesis | 1 | 2019 | 58 | 0.590 |
Why?
| | Glycolysis | 4 | 2021 | 319 | 0.590 |
Why?
| | Serum Albumin | 3 | 2019 | 150 | 0.580 |
Why?
| | Tracheal Stenosis | 1 | 2018 | 31 | 0.570 |
Why?
| | Nerve Tissue Proteins | 2 | 2013 | 599 | 0.560 |
Why?
| | Liver Cirrhosis | 3 | 2025 | 316 | 0.550 |
Why?
| | Airway Obstruction | 1 | 2019 | 162 | 0.540 |
Why?
| | Diet, Western | 4 | 2025 | 81 | 0.500 |
Why?
| | Fluorescein-5-isothiocyanate | 3 | 2014 | 36 | 0.490 |
Why?
| | Oxidative Phosphorylation | 3 | 2021 | 193 | 0.460 |
Why?
| | Gene Expression Regulation | 4 | 2021 | 2615 | 0.450 |
Why?
| | Disease Models, Animal | 11 | 2025 | 4295 | 0.450 |
Why?
| | Mice | 23 | 2025 | 17843 | 0.440 |
Why?
| | Caveolae | 1 | 2014 | 17 | 0.440 |
Why?
| | Cytochrome P-450 CYP2E1 | 3 | 2025 | 31 | 0.430 |
Why?
| | Rabbits | 3 | 2020 | 792 | 0.420 |
Why?
| | Bile Acids and Salts | 4 | 2025 | 200 | 0.390 |
Why?
| | Receptors, G-Protein-Coupled | 4 | 2022 | 222 | 0.380 |
Why?
| | Cysts | 2 | 2022 | 111 | 0.330 |
Why?
| | Kidney | 4 | 2019 | 1472 | 0.320 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2023 | 278 | 0.310 |
Why?
| | Pregnancy | 11 | 2025 | 6745 | 0.310 |
Why?
| | Diabetic Nephropathies | 3 | 2017 | 293 | 0.310 |
Why?
| | Optical Imaging | 2 | 2021 | 63 | 0.300 |
Why?
| | Pulmonary Surfactants | 2 | 2020 | 106 | 0.300 |
Why?
| | Fetal Growth Retardation | 2 | 2024 | 565 | 0.300 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 3 | 2025 | 220 | 0.290 |
Why?
| | Lysosomes | 3 | 2014 | 142 | 0.290 |
Why?
| | Hypoxia | 2 | 2025 | 1108 | 0.280 |
Why?
| | Trachea | 2 | 2020 | 236 | 0.280 |
Why?
| | Hepacivirus | 3 | 2015 | 258 | 0.280 |
Why?
| | Signal Transduction | 11 | 2025 | 5096 | 0.270 |
Why?
| | Extracellular Matrix | 2 | 2021 | 528 | 0.270 |
Why?
| | Receptors, Fc | 2 | 2019 | 53 | 0.250 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 621 | 0.250 |
Why?
| | Vero Cells | 1 | 2006 | 67 | 0.250 |
Why?
| | Pseudopodia | 1 | 2006 | 26 | 0.250 |
Why?
| | Vascular Remodeling | 2 | 2025 | 190 | 0.250 |
Why?
| | Fetal Hypoxia | 1 | 2025 | 54 | 0.230 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2023 | 108 | 0.220 |
Why?
| | Glucagon | 1 | 2025 | 109 | 0.220 |
Why?
| | Microglia | 2 | 2024 | 251 | 0.220 |
Why?
| | Chorionic Villi | 1 | 2024 | 23 | 0.220 |
Why?
| | Metabolomics | 2 | 2020 | 679 | 0.210 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2025 | 175 | 0.210 |
Why?
| | Umbilical Arteries | 1 | 2024 | 54 | 0.210 |
Why?
| | Microtubules | 1 | 2006 | 270 | 0.210 |
Why?
| | Eukaryotic Initiation Factor-2B | 1 | 2023 | 6 | 0.200 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2024 | 70 | 0.200 |
Why?
| | Microscopy, Fluorescence | 2 | 2016 | 402 | 0.200 |
Why?
| | Humans | 38 | 2025 | 137514 | 0.200 |
Why?
| | Cell Line | 5 | 2017 | 2852 | 0.200 |
Why?
| | Sirtuin 3 | 1 | 2023 | 61 | 0.200 |
Why?
| | Female | 22 | 2025 | 73162 | 0.200 |
Why?
| | Hypertension, Pulmonary | 2 | 2025 | 1903 | 0.200 |
Why?
| | Fibrosis | 6 | 2023 | 552 | 0.200 |
Why?
| | Saccharopolyspora | 1 | 2022 | 6 | 0.200 |
Why?
| | Endotoxemia | 1 | 2023 | 86 | 0.190 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2024 | 316 | 0.190 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2022 | 30 | 0.190 |
Why?
| | Leukocytes | 1 | 2024 | 311 | 0.190 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2019 | 194 | 0.190 |
Why?
| | Kidney Diseases | 2 | 2017 | 407 | 0.190 |
Why?
| | Primates | 4 | 2024 | 125 | 0.190 |
Why?
| | Gain of Function Mutation | 2 | 2018 | 36 | 0.190 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2022 | 51 | 0.180 |
Why?
| | Assisted Circulation | 1 | 2021 | 26 | 0.180 |
Why?
| | Bone Marrow | 1 | 2023 | 286 | 0.180 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2022 | 97 | 0.180 |
Why?
| | Mice, Inbred ICR | 1 | 2021 | 120 | 0.180 |
Why?
| | Heart Murmurs | 1 | 2021 | 14 | 0.180 |
Why?
| | Cell Movement | 1 | 2006 | 972 | 0.180 |
Why?
| | Amino Acids | 1 | 2025 | 503 | 0.180 |
Why?
| | Rats | 6 | 2019 | 5676 | 0.180 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2022 | 139 | 0.170 |
Why?
| | Phosphates | 2 | 2013 | 184 | 0.170 |
Why?
| | Phenotype | 3 | 2024 | 3205 | 0.170 |
Why?
| | Placenta | 2 | 2025 | 754 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2024 | 275 | 0.170 |
Why?
| | Male | 17 | 2025 | 67718 | 0.170 |
Why?
| | Kidney Tubules | 2 | 2019 | 117 | 0.170 |
Why?
| | Epithelium | 1 | 2021 | 315 | 0.170 |
Why?
| | Aortic Diseases | 1 | 2021 | 117 | 0.170 |
Why?
| | Hepatitis C | 2 | 2015 | 263 | 0.160 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 398 | 0.160 |
Why?
| | Cholic Acids | 2 | 2017 | 18 | 0.160 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 137 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 211 | 0.160 |
Why?
| | Cellular Senescence | 1 | 2021 | 188 | 0.160 |
Why?
| | Molecular Imaging | 1 | 2019 | 55 | 0.160 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 144 | 0.150 |
Why?
| | NF-kappa B | 1 | 2023 | 694 | 0.150 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 5792 | 0.150 |
Why?
| | Mice, Knockout | 6 | 2025 | 3020 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 4 | 2022 | 2420 | 0.150 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2019 | 38 | 0.150 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 75 | 0.150 |
Why?
| | Ventricular Remodeling | 1 | 2021 | 262 | 0.150 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 46 | 0.150 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 350 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 3 | 2014 | 2501 | 0.150 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 608 | 0.140 |
Why?
| | Biomarkers | 3 | 2021 | 4172 | 0.140 |
Why?
| | Sheep | 3 | 2025 | 855 | 0.140 |
Why?
| | Organ Size | 1 | 2019 | 479 | 0.140 |
Why?
| | Telomere | 1 | 2021 | 280 | 0.140 |
Why?
| | Lipid Metabolism | 2 | 2022 | 511 | 0.140 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 4 | 0.140 |
Why?
| | Alzheimer Disease | 1 | 2024 | 559 | 0.140 |
Why?
| | Relaxin | 1 | 2017 | 20 | 0.140 |
Why?
| | 5'-Nucleotidase | 1 | 2017 | 41 | 0.140 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 203 | 0.140 |
Why?
| | Insulin | 2 | 2025 | 2398 | 0.140 |
Why?
| | Arrhythmias, Cardiac | 1 | 2020 | 331 | 0.130 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 48 | 0.130 |
Why?
| | Glucuronidase | 1 | 2017 | 45 | 0.130 |
Why?
| | Gangliosides | 1 | 2017 | 20 | 0.130 |
Why?
| | Membrane Microdomains | 1 | 2017 | 33 | 0.130 |
Why?
| | Salmonella enterica | 1 | 2017 | 57 | 0.130 |
Why?
| | Nephrosclerosis | 1 | 2016 | 6 | 0.130 |
Why?
| | Protein Transport | 2 | 2019 | 443 | 0.130 |
Why?
| | Proteolysis | 2 | 2014 | 180 | 0.130 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2020 | 383 | 0.130 |
Why?
| | Cell Polarity | 2 | 2014 | 141 | 0.130 |
Why?
| | Adenosine | 1 | 2017 | 227 | 0.120 |
Why?
| | Myocardium | 2 | 2020 | 1004 | 0.120 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2015 | 19 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 531 | 0.120 |
Why?
| | Lung Diseases | 1 | 2022 | 768 | 0.120 |
Why?
| | Heart-Assist Devices | 1 | 2021 | 550 | 0.120 |
Why?
| | Claudin-1 | 1 | 2015 | 15 | 0.120 |
Why?
| | Obesity | 3 | 2019 | 2974 | 0.120 |
Why?
| | Renal Insufficiency | 1 | 2017 | 157 | 0.120 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2017 | 379 | 0.120 |
Why?
| | Clathrin | 2 | 2014 | 26 | 0.110 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2015 | 72 | 0.110 |
Why?
| | Epithelial Cells | 3 | 2018 | 1099 | 0.110 |
Why?
| | Mitochondria | 4 | 2025 | 947 | 0.110 |
Why?
| | Autocrine Communication | 1 | 2014 | 41 | 0.110 |
Why?
| | Tight Junctions | 1 | 2015 | 77 | 0.110 |
Why?
| | Immunoglobulin G | 1 | 2019 | 886 | 0.110 |
Why?
| | Transcytosis | 1 | 2014 | 7 | 0.110 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 367 | 0.110 |
Why?
| | Microvilli | 2 | 2012 | 79 | 0.110 |
Why?
| | Interleukin-10 Receptor alpha Subunit | 1 | 2013 | 5 | 0.110 |
Why?
| | Aging | 3 | 2024 | 1866 | 0.110 |
Why?
| | Colitis | 2 | 2013 | 265 | 0.110 |
Why?
| | Fibroblasts | 3 | 2025 | 990 | 0.110 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2013 | 17 | 0.110 |
Why?
| | Oxidative Stress | 4 | 2025 | 1307 | 0.110 |
Why?
| | Albumins | 1 | 2014 | 114 | 0.110 |
Why?
| | Creatine Kinase | 1 | 2013 | 79 | 0.110 |
Why?
| | Creatine | 1 | 2013 | 60 | 0.110 |
Why?
| | Immunity, Innate | 4 | 2023 | 832 | 0.100 |
Why?
| | Exosomes | 1 | 2014 | 103 | 0.100 |
Why?
| | Heart | 1 | 2017 | 660 | 0.100 |
Why?
| | Transcriptome | 1 | 2020 | 974 | 0.100 |
Why?
| | Protease Inhibitors | 1 | 2014 | 107 | 0.100 |
Why?
| | Trophoblasts | 1 | 2015 | 198 | 0.100 |
Why?
| | Didelphis | 1 | 2013 | 3 | 0.100 |
Why?
| | Vesicular Transport Proteins | 1 | 2014 | 84 | 0.100 |
Why?
| | Interferons | 1 | 2014 | 199 | 0.100 |
Why?
| | Interferon-gamma | 2 | 2013 | 790 | 0.100 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2012 | 9 | 0.100 |
Why?
| | Cell Hypoxia | 1 | 2013 | 227 | 0.100 |
Why?
| | Enterocytes | 1 | 2012 | 16 | 0.100 |
Why?
| | Brain | 2 | 2024 | 2831 | 0.100 |
Why?
| | Sodium-Hydrogen Exchangers | 1 | 2012 | 26 | 0.100 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 616 | 0.100 |
Why?
| | Killer Cells, Natural | 1 | 2015 | 446 | 0.090 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 634 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 302 | 0.090 |
Why?
| | Virus Replication | 1 | 2014 | 480 | 0.090 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2013 | 177 | 0.090 |
Why?
| | Green Fluorescent Proteins | 1 | 2013 | 394 | 0.090 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2015 | 389 | 0.090 |
Why?
| | RNA Interference | 1 | 2013 | 464 | 0.090 |
Why?
| | RNA, Messenger | 4 | 2021 | 2838 | 0.090 |
Why?
| | Phosphorus, Dietary | 1 | 2010 | 4 | 0.090 |
Why?
| | Kidney Cortex | 1 | 2010 | 26 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 621 | 0.080 |
Why?
| | Kinetics | 1 | 2014 | 1679 | 0.080 |
Why?
| | Glomerular Filtration Rate | 1 | 2014 | 746 | 0.080 |
Why?
| | Galectins | 1 | 2010 | 24 | 0.080 |
Why?
| | Phosphoproteins | 1 | 2012 | 338 | 0.080 |
Why?
| | Kupffer Cells | 1 | 2010 | 50 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3722 | 0.080 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2010 | 93 | 0.080 |
Why?
| | Arthritis, Rheumatoid | 1 | 2018 | 1163 | 0.080 |
Why?
| | Biophysical Phenomena | 2 | 2021 | 65 | 0.080 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 451 | 0.080 |
Why?
| | Endosomes | 1 | 2010 | 136 | 0.080 |
Why?
| | Cell Membrane | 1 | 2013 | 751 | 0.080 |
Why?
| | Endothelial Cells | 1 | 2014 | 780 | 0.080 |
Why?
| | STAT3 Transcription Factor | 2 | 2025 | 208 | 0.080 |
Why?
| | Promoter Regions, Genetic | 3 | 2018 | 1255 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2019 | 4206 | 0.070 |
Why?
| | Longevity | 2 | 2022 | 165 | 0.070 |
Why?
| | Hypertension | 1 | 2017 | 1293 | 0.070 |
Why?
| | Heart Failure | 1 | 2021 | 2222 | 0.070 |
Why?
| | Mice, Transgenic | 3 | 2019 | 2182 | 0.070 |
Why?
| | Cohort Studies | 3 | 2024 | 5730 | 0.070 |
Why?
| | Nocodazole | 1 | 2006 | 16 | 0.060 |
Why?
| | Diacetyl | 1 | 2006 | 7 | 0.060 |
Why?
| | Thiazolidines | 1 | 2006 | 10 | 0.060 |
Why?
| | Middle Aged | 6 | 2024 | 33355 | 0.060 |
Why?
| | Platelet Factor 4 | 1 | 2025 | 35 | 0.060 |
Why?
| | Receptors, Glucagon | 1 | 2025 | 28 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2025 | 79 | 0.060 |
Why?
| | Blood Glucose | 2 | 2025 | 2183 | 0.060 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 93 | 0.060 |
Why?
| | Platelet Activation | 1 | 2025 | 93 | 0.060 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2006 | 228 | 0.050 |
Why?
| | Inflammation | 3 | 2022 | 2837 | 0.050 |
Why?
| | Placental Insufficiency | 1 | 2024 | 116 | 0.050 |
Why?
| | Ultrasonography, Doppler | 1 | 2024 | 123 | 0.050 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2023 | 26 | 0.050 |
Why?
| | NAD | 1 | 2023 | 77 | 0.050 |
Why?
| | Immunophenotyping | 1 | 2024 | 321 | 0.050 |
Why?
| | PQQ Cofactor | 1 | 2022 | 5 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2024 | 223 | 0.050 |
Why?
| | Aged | 4 | 2024 | 23798 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2017 | 1357 | 0.050 |
Why?
| | PPAR alpha | 1 | 2022 | 59 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2017 | 734 | 0.050 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2021 | 12 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2025 | 405 | 0.050 |
Why?
| | Long Term Adverse Effects | 1 | 2021 | 12 | 0.050 |
Why?
| | ADAMTS4 Protein | 1 | 2021 | 16 | 0.050 |
Why?
| | Tyrphostins | 1 | 2021 | 17 | 0.050 |
Why?
| | Amphiregulin | 1 | 2021 | 25 | 0.050 |
Why?
| | Fetal Development | 1 | 2024 | 296 | 0.050 |
Why?
| | Blood Platelets | 1 | 2025 | 405 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1999 | 0.050 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 257 | 0.040 |
Why?
| | Keratin-5 | 1 | 2021 | 50 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2024 | 501 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 197 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 778 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 361 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 982 | 0.040 |
Why?
| | Substrate Specificity | 1 | 2021 | 385 | 0.040 |
Why?
| | Cilia | 1 | 2022 | 186 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2022 | 248 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2023 | 411 | 0.040 |
Why?
| | Uterus | 1 | 2021 | 215 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 381 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2014 | 1185 | 0.040 |
Why?
| | Premature Birth | 1 | 2024 | 331 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2021 | 299 | 0.040 |
Why?
| | Maternal Exposure | 1 | 2021 | 188 | 0.040 |
Why?
| | Quinazolines | 1 | 2021 | 249 | 0.040 |
Why?
| | Keratin-15 | 1 | 2019 | 16 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2022 | 654 | 0.040 |
Why?
| | Colloids | 1 | 2019 | 60 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 309 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 197 | 0.040 |
Why?
| | Receptors, Leukotriene | 1 | 2019 | 14 | 0.040 |
Why?
| | Antioxidants | 1 | 2023 | 577 | 0.040 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2019 | 43 | 0.040 |
Why?
| | Expectorants | 1 | 2018 | 24 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2020 | 165 | 0.040 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2022 | 252 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2021 | 619 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2018 | 45 | 0.040 |
Why?
| | Kidney Glomerulus | 1 | 2019 | 114 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2020 | 502 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 429 | 0.040 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 152 | 0.040 |
Why?
| | Ureteral Obstruction | 1 | 2019 | 64 | 0.040 |
Why?
| | Chenodeoxycholic Acid | 1 | 2017 | 16 | 0.040 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 21 | 0.040 |
Why?
| | Nucleotidases | 1 | 2017 | 7 | 0.040 |
Why?
| | Polycystic Kidney Diseases | 1 | 2019 | 76 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2021 | 616 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2022 | 563 | 0.040 |
Why?
| | Mitochondrial Turnover | 1 | 2017 | 5 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 200 | 0.030 |
Why?
| | Bacterial Load | 1 | 2017 | 68 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1505 | 0.030 |
Why?
| | Heart Function Tests | 1 | 2017 | 61 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 784 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 447 | 0.030 |
Why?
| | DNA Methylation | 1 | 2022 | 644 | 0.030 |
Why?
| | Urinalysis | 1 | 2017 | 77 | 0.030 |
Why?
| | Gelatin | 1 | 2017 | 50 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2021 | 1740 | 0.030 |
Why?
| | Sodium-Glucose Transporter 2 | 1 | 2017 | 24 | 0.030 |
Why?
| | Kidney Function Tests | 1 | 2017 | 158 | 0.030 |
Why?
| | Pancreas | 1 | 2019 | 328 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2017 | 300 | 0.030 |
Why?
| | Hypolipidemic Agents | 1 | 2017 | 92 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 185 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2017 | 121 | 0.030 |
Why?
| | RNA | 1 | 2022 | 924 | 0.030 |
Why?
| | Salmonella typhimurium | 1 | 2017 | 182 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 1063 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1460 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 413 | 0.030 |
Why?
| | Triglycerides | 1 | 2017 | 525 | 0.030 |
Why?
| | Tissue Scaffolds | 1 | 2017 | 210 | 0.030 |
Why?
| | HeLa Cells | 1 | 2017 | 640 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2066 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 139 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2017 | 366 | 0.030 |
Why?
| | Denys-Drash Syndrome | 1 | 2014 | 4 | 0.030 |
Why?
| | WT1 Proteins | 1 | 2014 | 15 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 377 | 0.030 |
Why?
| | Suppressor of Cytokine Signaling 3 Protein | 1 | 2013 | 9 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 514 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 632 | 0.030 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 21 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2015 | 320 | 0.030 |
Why?
| | Adult | 3 | 2024 | 37821 | 0.030 |
Why?
| | Dextran Sulfate | 1 | 2013 | 83 | 0.030 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2015 | 182 | 0.030 |
Why?
| | Permeability | 1 | 2013 | 162 | 0.030 |
Why?
| | Dextrans | 1 | 2013 | 84 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2013 | 155 | 0.030 |
Why?
| | Hepatocytes | 1 | 2014 | 220 | 0.030 |
Why?
| | Genotype | 1 | 2018 | 1920 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2015 | 346 | 0.030 |
Why?
| | Tissue Engineering | 1 | 2017 | 418 | 0.030 |
Why?
| | Transcription Factors | 1 | 2021 | 1717 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2017 | 528 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2015 | 379 | 0.030 |
Why?
| | Interleukins | 1 | 2014 | 251 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 386 | 0.020 |
Why?
| | DNA Primers | 1 | 2013 | 514 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 329 | 0.020 |
Why?
| | Caco-2 Cells | 1 | 2012 | 77 | 0.020 |
Why?
| | Neurons | 1 | 2021 | 1613 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 856 | 0.020 |
Why?
| | Cytoskeletal Proteins | 1 | 2012 | 156 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 595 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1227 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2014 | 425 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1324 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2013 | 1061 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2022 | 6059 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1776 | 0.020 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 12 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 869 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 84 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2755 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2010 | 141 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 455 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 191 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3420 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 770 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 665 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 558 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10356 | 0.020 |
Why?
| | Monocytes | 1 | 2010 | 568 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 15628 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2012 | 1167 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 2095 | 0.020 |
Why?
| | Immunotherapy | 1 | 2010 | 647 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 1092 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2521 | 0.010 |
Why?
| | Child | 1 | 2022 | 22037 | 0.010 |
Why?
| | Macrophages | 1 | 2010 | 1548 | 0.010 |
Why?
|
|
Dobrinskikh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|